Y-mAbs Therapeutics, Inc. (YMAB) - Balance Sheet Statement

Home
YMAB
Financials

8.28 (USD) • At close December 20, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2023	2022	2021	2020	2019	2018	2017	2016
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	78.637	105.762	181.564	114.634	207.136	147.84	90.483	16.875
Short Term Investments Numbers are in millions	0	0	0	0	0	0	0	0
Cash and Short Term Investments Numbers are in millions	78.637	105.762	181.564	114.634	207.136	147.84	90.483	16.875
Net Receivables Numbers are in millions	22.454	12.531	7.712	0	0	0	0	0
Inventory Numbers are in millions	5.065	6.702	5.512	-0.8	0	0	0	0
Other Current Assets Numbers are in millions	4.955	5.452	7.473	7.729	4.819	3.692	0.872	0.386
Total Current Assets Numbers are in millions	111.111	130.447	202.261	122.363	211.955	151.532	91.355	17.261
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	1.636	2.343	5.689	6.394	4.041	0.205	0	0
Goodwill Numbers are in millions	0	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	2.631	2.986	1.663	0	0	0	0	0
Goodwill and Intangible Assets Numbers are in millions	2.631	2.986	1.663	0	0	0	0	0
Long Term Investments Numbers are in millions	0	0	0	0	0	0	0	0
Tax Assets Numbers are in millions	0	0	0	0	0	0	0	0
Other Non-Current Assets Numbers are in millions	12.491	5.68	3.17	3.29	0.37	0.187	0.772	0
Total Non-Current Assets Numbers are in millions	16.758	11.009	10.522	9.684	4.411	0.392	0.772	0
Total Assets Numbers are in millions	127.869	141.456	212.783	132.047	216.366	151.924	92.127	17.261
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	6.06	14.175	13.552	9.372	8.52	5.872	5.909	2.227
Short Term Debt Numbers are in millions	1.804	1.736	3.566	3.932	1.032	0	0	0
Tax Payables Numbers are in millions	0	0	0	0	0	0	0	0
Deferred Revenue Numbers are in millions	0	0	0	0	0	0	0	0
Other Current Liabilities Numbers are in millions	12.264	12.373	10.757	6.231	4.034	3.251	2.016	0.748
Total Current Liabilities Numbers are in millions	20.128	28.284	27.875	19.535	13.586	9.123	7.925	2.975
Non-Current Liabilities:
Long Term Debt Numbers are in millions	0.517	0.899	1.851	2.013	1.714	0	0	0
Deferred Revenue Non-Current Numbers are in millions	0	0	0	0	0	0	0	0
Deferred Tax Liabilities Non-Current Numbers are in millions	0	0	0	0	0	0	0	0
Other Non-Current Liabilities Numbers are in millions	6.239	3.052	2.951	4.663	2.163	2.274	2.05	2.225
Total Non-Current Liabilities Numbers are in millions	6.756	3.951	4.802	6.676	3.877	2.274	2.05	2.225
Total Liabilities Numbers are in millions	26.884	32.235	32.677	26.211	17.463	11.397	9.975	5.2
Equity:
Preferred Stock Numbers are in millions	0	0	0	0	0	0	0	0
Common Stock Numbers are in millions	0.004	0.004	0.004	0.004	0.004	0.003	0.003	0.002
Retained Earnings Numbers are in millions	-457.47	-436.043	-340.475	-285.2	-165.863	-84.835	-41.561	-22.4
Accumulated Other Comprehensive Income/Loss Numbers are in millions	0.449	1.331	1.371	-0.526	0.05	0.007	-0.169	0.03
Other Total Stockholders Equity Numbers are in millions	558.002	543.929	519.206	391.558	364.712	225.352	123.879	34.429
Total Shareholders Equity Numbers are in millions	100.985	109.221	180.106	105.836	198.903	140.527	82.152	12.061
Total Equity Numbers are in millions	100.985	109.221	180.106	105.836	198.903	140.527	82.152	12.061
Total Liabilities & Shareholders Equity Numbers are in millions	127.869	141.456	212.783	132.047	216.366	151.924	92.127	17.261

Y-mAbs Therapeutics, Inc.

NASDAQ:YMAB Add to watchlist

NASDAQ:YMAB